Charity Impact Media

Home › Diseases, disorders & medical disciplines

National Psoriasis Foundation

Alexandria, VA · EIN 93-0571472 · 501(c)(3) · Publicly supported organization (170(b)(1)(A)(vi))
Latest filing: Form 990 for the fiscal year ending June 30, 2025 (tax year 2024) · View the filing · Correct or respond

National Psoriasis Foundation reported $12.6 million in revenue and $11.7 million in expenses for the fiscal year ending June 30, 2025. Of every $100 it spent, $78.66 went to program services, $11.04 to management and general costs and $10.30 to fundraising. Its largest source of revenue was contributions and grants: 83.7% of the total. The highest compensation it reported for one person was $442,827 (PRESIDENT/CEO). 9 people received more than $100,000 in reportable compensation. Revenue fell 11% between FY2020 and FY2025. Source: Form 990, FY2025.

Where $100 of spending went

The fiscal year ending June 30, 2025 · Form 990, Part IX, line 25 · total expenses $12M

For context, the median across 314 covered diseases, disorders & medical disciplines charities: $88.73 programs, $10.89 management, $0.38 fundraising (medians computed separately, so they may not sum to $100).

Where $100 of revenue came from

The fiscal year ending June 30, 2025 · Form 990, Part VIII · total revenue $13M

Other revenue was negative: −$681K. The bar shows the positive sources only.

The 990 scorecard · same measures for every charity, no grades

FY2025 filing. Median across 314 covered charities in this category, from their latest filings.
MeasureFY2025Median
Program services
Part IX 25(B) ÷ 25(A)
78.7%86.7%
Management & general
Part IX 25(C) ÷ 25(A)
11.0%10.6%
Fundraising
Part IX 25(D) ÷ 25(A)
10.3%0.4%
Fundraising cost per $1 of contributions
Part IX 25(D) ÷ Part VIII 1h
$0.11$0.03
Contributions & grants share of revenue
Part VIII 1h ÷ 12
83.7%24.7%
Government grants share of revenue
Part VIII 1e ÷ 12
3.2%0.6%
Program service revenue share
Part VIII 2g ÷ 12
16.0%59.5%
Highest reported compensation
Part VII-A, columns D–F
$442,827$391,657
Highest compensation as share of expenses
Part VII-A ÷ Part IX 25(A)
3.77%1.45%
People paid over $100,000
Part VII, line 2
910
Net assets, in months of expenses
Part X 33(B) ÷ monthly expenses
10.27.6
Independent voting board members
Part VI 1a–1b
19 of 19100.0%

A median is context, not a target: hospitals, universities, food banks and grantmakers spend in very different ways. What these measures can and can't tell you.

What the money paid for, in its own words

FY2025 · Form 990, Part III · the three largest programs by expense
$3.4M expenses · 37.3% of program spending · grants $2.5M

Researchthe National Psoriasis Foundation (npf) continues to be a leader in funding and driving research to cure psoriatic disease. In FY 2025, npf invested over $2.5m in research grants and fellowship awards towards outside-the-box ideas and supported young researchers, ensuring progress toward novel treatments. Through partnerships such as the accelerated medicines partnership for autoimmune and immune-mediated diseases (amp aim), npf has worked with industry and nonprofit stakeholders to identify molecular pathways and accelerate treatment development. Bridge grants have enabled near-miss…

$1.3M expenses · 14.3% of program spending · revenue $12,000

Professional educationnpf continued to expand and strengthen medical education programming targeting health care providers at all levels and stages of career. The 26th annual residents and rheumatology fellows meeting offered dermatology residents and rheumatology fellows the latest in psoriatic disease treatment presented by experts in the field. Through its dedication to educating health care providers on psoriatic disease and its related diseases, npf has earned accreditation as a provider of continuing medical education. It's part of our efforts to ensure all different types of health…

$1.2M expenses · 13.1% of program spending

Advocacynpf further amplified its advocacy efforts. The organization continues to champion patient-friendly legislation, notably the safe step act, and has supported step therapy reforms and copay accumulator protections across 40 states. Npf regularly advocates on capitol hill for better care, access, and fair pricing. In FY 2025, npf proactively educated its community about significant medicare changes through articles, podcasts, and webinars, helping patients navigate new out-of-pocket maximums and prescription options

$3.3M all other programs (line 4d)

Highest reported compensation

FY2025 · Form 990, Part VII, Section A · roles as filed; names are in the filing, not here
RoleFrom this orgFrom related orgsOtherTotal
PRESIDENT/CEO
Officer, 40.00 hrs/week
$399,224$0$43,603$442,827
CHIEF SCIENTIFC & MEDICAL OFFICER
Key employee, 40.00 hrs/week
$254,350$0$33,812$288,162
CHIEF REVENUE OFFICER
Key employee, 40.00 hrs/week
$231,654$0$47,071$278,725
CHIEF FINANCIAL OFFICER
Officer, 40.00 hrs/week
$226,395$0$20,625$247,020
VICE PRESIDENT OF ADVANCEMENT
Highest compensated employee, 40.00 hrs/week
$160,412$0$22,921$183,333
VICE PRESIDENT OF GOVERNMENT RELATIONS & ADVOCACY
Highest compensated employee, 40.00 hrs/week
$158,156$0$18,207$176,363
VICE PRESIDENT, FIELD DEVELOPMENT & OPERATIONS
Highest compensated employee, 40.00 hrs/week
$149,303$0$24,983$174,286
VICE PRESIDENT OF MARKETING & COMMUNICATIONS
Highest compensated employee, 40.00 hrs/week
$144,256$0$17,388$161,644

9 people received more than $100,000 in reportable compensation from National Psoriasis Foundation (Part VII, line 2). Compensation of current officers, directors and key employees totaled $1.2M (Part IX, line 5).

6 years of filings

Form 990, Parts I, VII, IX and X · each row is that year's own filing, linked
RevenueExpenses
$0$5.0M$10M$15M$20MFY2020FY2021FY2022FY2023FY2024FY2025$13M$12M
FilingRevenueExpensesProgramsNet assetsTop pay
FY2025 ⓘ$13M$12M78.7%$10.0M$442,827
FY2024 ⓘ$12M$13M77.0%$8.7M$339,959
FY2023 (amended) ⓘ$12M$14M77.1%$9.0M$312,272
FY2022 ⓘ$13M$13M77.3%$11M$434,179
FY2021 ⓘ$13M$11M74.8%$11M$587,406
FY2020 ⓘ$14M$14M75.8%$8.7M$337,925

Governance answers, as filed

FY2025 · the organization's own yes/no answers; explanations, if any, are in Schedule O of the filing · what each means
  • Voting board members, and how many are independent Part VI, lines 1a–1b19 · 19 independent
  • Audited financial statements Part XII 2bYes
  • Conflict-of-interest policy Part VI 12aYes
  • Whistleblower policy Part VI 13Yes
  • Document retention policy Part VI 14Yes
  • Independent process for top executive pay Part VI 15aYes
  • Board given the 990 before filing Part VI 11aYes
  • Family or business ties among insiders Part VI 2No
  • Aware of a significant diversion of assets Part VI 5No
  • Excess benefit transaction with an insider Part IV 25aNo
  • Loans to or from insiders outstanding Part IV 26No
  • Lobbying, or a 501(h) election in effect Part IV 4Yes
  • Over $15,000 of professional fundraising services Part IV 18No
  • Over $10,000 of activity outside the U.S. Part IV 14bYes
  • Employees Part I, line 557
  • Volunteers Part I, line 6624

Largest outside contractors

FY2025 · Form 990, Part VII, Section B · businesses only
RATIONAL 360 INC
Direct marketing agency
$137,000
BRG COMMUNICATIONS INC
Public relations
$106,500

Individuals listed as contractors are left out. 2 contractors were paid more than $100,000 in all.

Private foundation grants it received

41 private foundations reported grants to National Psoriasis Foundation totaling $321K on their tax year 2023 Form 990-PF returns. See which foundations, on WHOFUNDS.

Source: WHOFUNDS open grant graph, matched from Form 990-PF Part XV.

Correct a figure or respond

Every number above is copied from National Psoriasis Foundation's own Form 990. If one doesn't match the filing, that's our error and we'll fix it. If you work for National Psoriasis Foundation, you can publish a response that is linked from this page.

Similar-sized charities in this cause

All diseases, disorders & medical disciplines charities · Largest charities in Virginia

Questions people ask

How much of National Psoriasis Foundation's spending goes to programs?

In the fiscal year ending June 30, 2025, National Psoriasis Foundation reported that 78.7% of its $11.7 million in expenses went to program services, 11.0% to management and general and 10.3% to fundraising (Form 990, Part IX).

How much does National Psoriasis Foundation pay its top executive?

The largest total compensation National Psoriasis Foundation reported for one person in the fiscal year ending June 30, 2025 was $442,827, for the role of PRESIDENT/CEO (Form 990, Part VII, including compensation from related organizations and other compensation).

Where does National Psoriasis Foundation get its money?

Of $12.6 million in revenue in the fiscal year ending June 30, 2025, 83.7% came from contributions and grants (including 3.2% from government grants) and 16.0% from program service revenue (Form 990, Part VIII).

Is National Psoriasis Foundation a registered charity?

The IRS lists EIN 93-0571472 as a 501(c)(3) organization (publicly supported organization (170(b)(1)(a)(vi))), and its records show contributions as tax-deductible. Form 990 filings on record here cover tax years 2019, 2020, 2021, 2022, 2023, 2024. A filing shows what the organization reported; it doesn't by itself show whether a program works.

Sources

  • FY2025: Form 990 for the fiscal year ending June 30, 2025, object 202543539349301419 · read the filing · XML
  • FY2024: Form 990 for the fiscal year ending June 30, 2024, object 202530319349300033 · read the filing
  • FY2023: Form 990 for the fiscal year ending June 30, 2023 (amended), object 202432979349301428 · read the filing
  • FY2022: Form 990 for the fiscal year ending June 30, 2022, object 202243579349300319 · read the filing
  • FY2021: Form 990 for the fiscal year ending June 30, 2021, object 202113149349307441 · read the filing
  • FY2020: Form 990 for the fiscal year ending June 30, 2020, object 202033219349318073 · read the filing

All filings for EIN 93-0571472: ProPublica Nonprofit Explorer · IRS Tax Exempt Organization Search. Figures are as the organization reported them; we have not audited them.